research use only

Chitosan

Cat.No.E4299

Chitosan(Deacetylated chitin (MW 150000); Poly(D-glucosamine) (MW 150000)) is a polycationic linear polysaccharide derived from chitin with the molecular weight of 150000. This compound is an versatile biomaterial because of its non-toxicity, low allergenicity, biocompatibility and biodegradability. It also has antitumor, antibacterial, antifungal, and antioxidant activities.
Chitosan Chemical Structure

Chemical Structure

Molecular Weight:

Quality Control

Chemical Information, Storage & Stability

Molecular Weight Formula Storage (From the date of receipt)
CAS No. 9012-76-4 -- Storage of Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03712371 Terminated
Prostate Cancer
Medical University of South Carolina
January 16 2019 Phase 1|Phase 2
NCT03724266 Unknown status
Postoperative Pain|Healing
Cairo University
October 2018 Not Applicable
NCT02151279 Unknown status
Shellfish Allergy
Universidade do Porto|Aveiro University
March 2014 Not Applicable

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.